LTR Pharma Limited (AU:LTP) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LTR Pharma Limited is set to capture attention in the financial markets with its new fast-acting nasal spray treatment for erectile dysfunction, targeting sophisticated investors across multiple countries. The company is actively engaging with institutional accredited investors for capital raising opportunities.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.